相似文献
1
Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
Antimicrob Agents Chemother. 1978 Aug;14(2):240-5. doi: 10.1128/AAC.14.2.240.
2
[Antibacterial activity of pipemidic acid].
Ann Ist Super Sanita. 1982;18(3):467-70.
3
New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity.
J Bacteriol. 1981 Nov;148(2):450-8. doi: 10.1128/jb.148.2.450-458.1981.
4
Mutation affecting resistance of Escherichia coli K12 to nalidixic acid.
J Gen Microbiol. 1985 Sep;131(9):2285-92. doi: 10.1099/00221287-131-9-2285.
5
Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes.
Antimicrob Agents Chemother. 1982 Aug;22(2):242-9. doi: 10.1128/AAC.22.2.242.
6
[Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].
Dtsch Med Wochenschr. 1979 Jun 29;104(26):946-8. doi: 10.1055/s-0028-1104021.
7
Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.
J Bacteriol. 1969 Jul;99(1):238-41. doi: 10.1128/jb.99.1.238-241.1969.
8
The activity of pipemidic acid and piromidic acid against Escherichia coli in static culture and in conditions stimulating the treatment of bacterial cystitis.
J Appl Bacteriol. 1978 Apr;44(2):191-7. doi: 10.1111/j.1365-2672.1978.tb00790.x.
9
Cross resistance of quinolone derivatives in gram-negative bacteria.
Chemioterapia. 1985 Apr;4(2):192-6.
10
Activity of beta-hydroxy-piromidic acid against Staphylococcus aureus and enterobacteriaceae.
J Antimicrob Chemother. 1982 Jun;9(6):493-5. doi: 10.1093/jac/9.6.493.
引用本文的文献
1
Activities of fluoroquinolones against Streptococcus pneumoniae type II topoisomerases purified as recombinant proteins.
Antimicrob Agents Chemother. 1999 Nov;43(11):2579-85. doi: 10.1128/AAC.43.11.2579.
2
Classification and structure-activity relationships of fluoroquinolones.
Drugs. 1995;49 Suppl 2:16-28. doi: 10.2165/00003495-199500492-00005.
3
DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1995 Sep;39(9):1970-2. doi: 10.1128/AAC.39.9.1970.
4
Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli.
Antimicrob Agents Chemother. 1993 Apr;37(4):696-701. doi: 10.1128/AAC.37.4.696.
5
The future of the quinolones.
Drugs. 1993;45 Suppl 3:1-7. doi: 10.2165/00003495-199300453-00003.
6
Linkage map of Escherichia coli K-12, edition 6.
Microbiol Rev. 1980 Mar;44(1):1-56. doi: 10.1128/mr.44.1.1-56.1980.
7
Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes.
Antimicrob Agents Chemother. 1982 Aug;22(2):242-9. doi: 10.1128/AAC.22.2.242.
8
Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
Antimicrob Agents Chemother. 1982 Oct;22(4):662-71. doi: 10.1128/AAC.22.4.662.
9
New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity.
J Bacteriol. 1981 Nov;148(2):450-8. doi: 10.1128/jb.148.2.450-458.1981.
10
Mutational resistance to 4-quinolone antibacterial agents.
Eur J Clin Microbiol. 1984 Aug;3(4):347-50. doi: 10.1007/BF01977492.
本文引用的文献
1
Mutants of Escherichia coli requiring methionine or vitamin B12.
J Bacteriol. 1950 Jul;60(1):17-28. doi: 10.1128/jb.60.1.17-28.1950.
2
A NONSPECIFIC INCREASE IN PERMEABILITY IN ESCHERICHIA COLI PRODUCED BY EDTA.
Proc Natl Acad Sci U S A. 1965 Apr;53(4):745-50. doi: 10.1073/pnas.53.4.745.
3
1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS.
J Med Pharm Chem. 1962 Sep;5:1063-5. doi: 10.1021/jm01240a021.
4
Transduction of linked genetic characters of the host by bacteriophage P1.
Virology. 1955 Jul;1(2):190-206. doi: 10.1016/0042-6822(55)90016-7.
5
High-efficiency liquid-scintillation counting of 14C-labelled material in aqueous solution and determination of specific activity of labelled proteins.
Biochem J. 1965 Sep;96(3):626-33. doi: 10.1042/bj0960626.
6
A model for three-point analysis of random general transduction.
Genetics. 1966 Aug;54(2):405-10. doi: 10.1093/genetics/54.2.405.
7
Piromidic acid, a new antibacterial agent: antibacterial properties.
Antimicrob Agents Chemother (Bethesda). 1970;10:117-22.
8
Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.
J Bacteriol. 1969 Jul;99(1):238-41. doi: 10.1128/jb.99.1.238-241.1969.
9
Studies on the mechanism of action of nalidixic acid.
Antimicrob Agents Chemother. 1973 Oct;4(4):479-86. doi: 10.1128/AAC.4.4.479.
10
Pipemidic acid, a new antibacterial agent active against Pseudomonas aeruginosa: in vitro properties.
Antimicrob Agents Chemother. 1975 Aug;8(2):132-8. doi: 10.1128/AAC.8.2.132.
Zotero 插件